NCT00706394

Brief Summary

Study of anatomical fixation with a 34mm proximal extension

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2007

Longer than P75 for not_applicable

Geographic Reach
1 country

10 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 10, 2007

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

May 2, 2008

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 27, 2008

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2013

Completed
8.1 years until next milestone

Results Posted

Study results publicly available

October 20, 2021

Completed
Last Updated

November 1, 2021

Status Verified

October 1, 2021

Enrollment Period

6.1 years

First QC Date

May 2, 2008

Results QC Date

September 23, 2021

Last Update Submit

October 22, 2021

Conditions

Keywords

Powerlink34mmAbdominal Aortic AneurysmEVAR

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With Proximal Type I Endoleak at Each Timepoint

    Percentage of patients with Type Ia endoleaks at each timepoint (discharge, 1, 6, 12, 24, 36, 48 and 60 months).

    Five years

Secondary Outcomes (9)

  • Number of Participants With Successful Delivery and Deployment of the Device

    1 Month

  • Number of Participants With Type III Endoleaks at Each Timepoint

    5 Years

  • Number of Participants With Stent Fracture at Each Timepoint

    5 Years

  • Number of Participants With Stent Graft Obstruction at Each Timepoint

    5 Years

  • Number of Participants With Migration at Each Timepoint

    5 Years

  • +4 more secondary outcomes

Study Arms (1)

A

EXPERIMENTAL

Powerlink 34mm cuff stent graft

Device: Endologix Powerlink 34 mm stent graft cuff

Interventions

Endovascular abdominal aortic aneurysm repair

Also known as: Endologix Powerlink 34mm cuff [model 34-34-80L]
A

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years old or older
  • Informed consent understood and signed
  • Will comply with protocol follow-up requirements
  • Candidate for conventional open surgical repair
  • Aneurysm outer diameter is one or more of the following:
  • greater than or equal to 4.0cm
  • greater than or equal to 3.0cm (saccular aneurysm)
  • greater than or equal to twice the normal aortic outer diameter
  • rapidly growing (greater than or equal to 5mm over 6 months)
  • Proximal non-aneurysmal aortic neck fixation length greater than or equal to 1.5cm between the renal arteries and the aneurysm
  • Non-aneurysmal proximal aortic neck inner diameter between 23 and 32mm
  • Iliac artery internal diameter greater than or equal to 8 mm

You may not qualify if:

  • Life expectancy \<2 years
  • Participating in another clinical study
  • Pregnant or lactating women
  • Acutely ruptured/leaking aneurysm
  • Traumatic vascular injury
  • Other medical or psychiatric problems
  • Contraindication to non-ionic contrast media or anticoagulants
  • Coagulopathy or bleeding disorder
  • Active systemic or localized groin infection
  • Indispensable inferior mesenteric artery
  • Connective tissue disease (e.g., Marfan's Syndrome)
  • Creatinine level \>1.7 mg/dl
  • Renal transplant patient
  • Proximal attachment site \>60º angle to the aneurysm body
  • Iliac arteries \>90º angle
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (10)

Mount Sinai Medical Center

Miami, Florida, 33140, United States

Location

Baptist Cardiac and Vascular Institute

Miami, Florida, 33176, United States

Location

Baptist Hospital East

Louisville, Kentucky, 40207, United States

Location

St. Joseph Medical Center

Towson, Maryland, 21204, United States

Location

William Beaumont Hospital

Royal Oak, Michigan, 48073, United States

Location

Nebraska Heart Institute

Lincoln, Nebraska, 68526, United States

Location

Sisters of Charity Hospital

Buffalo, New York, 14214, United States

Location

Oklahoma Cardiovascular Associates

Oklahoma City, Oklahoma, 73120, United States

Location

Hospital at the University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Location

Lexington Medical Center

West Columbia, South Carolina, 29169, United States

Location

Related Publications (1)

  • Jordan WD Jr, Moore WM Jr, Melton JG, Brown OW, Carpenter JP; Endologix Investigators. Secure fixation following EVAR with the Powerlink XL System in wide aortic necks: results of a prospective, multicenter trial. J Vasc Surg. 2009 Nov;50(5):979-86. doi: 10.1016/j.jvs.2009.05.057. Epub 2009 Aug 12.

MeSH Terms

Conditions

Aortic Aneurysm, Abdominal

Condition Hierarchy (Ancestors)

Aortic AneurysmAneurysmVascular DiseasesCardiovascular DiseasesAortic Diseases

Results Point of Contact

Title
Sharone Trifskin
Organization
Endologix

Study Officials

  • Edward Y Woo, MD

    Hospital at the University of Pennsylvania, Philadelphia, PA 19104, United States

    PRINCIPAL INVESTIGATOR
  • O. W. Brown, MD

    William Beaumont Hospital, Royal Oak, MI 48073, United States

    PRINCIPAL INVESTIGATOR
  • James G. Melton, DO

    Oklahoma Cardiovascular Research Group, Oklahoma City, OK 73120, United States

    PRINCIPAL INVESTIGATOR
  • Steven H. Tyndall, MD

    Nebraska Heart Hospital, Lincoln, NE 68526, United States

    PRINCIPAL INVESTIGATOR
  • William M. Moore, MD

    Lexington Medical Center, West Columbia, SC 29169, United States

    PRINCIPAL INVESTIGATOR
  • Salem George, MD

    Baptist Hospital East, Louisville, KY 40207, United States

    PRINCIPAL INVESTIGATOR
  • Kerry C. Prewitt, MD

    St. Joseph Medical Center, Towson, MD 21204, United States

    PRINCIPAL INVESTIGATOR
  • Paul Anain, MD

    Sisters of Charity Hospital, Buffalo, NY 14214, United States

    PRINCIPAL INVESTIGATOR
  • Robert Beasley, MD

    Mount Sinai Medical Center, Miami Beach, FL 33140, United States

    PRINCIPAL INVESTIGATOR
  • Barry T. Katzen, MD

    Baptist Cardiac and Vascular Institute, Miami, FL 33176, United States

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
LTE60
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 2, 2008

First Posted

June 27, 2008

Study Start

August 10, 2007

Primary Completion

September 1, 2013

Study Completion

September 1, 2013

Last Updated

November 1, 2021

Results First Posted

October 20, 2021

Record last verified: 2021-10

Locations